The effect of an antibacterial drug on urinary calcium, magnesium and phosphorus excretion in patients with neurogenic bladder.
The effect of the simultaneous administration of hexamine mandelate and methionine on the urinary excretion of calcium, magnesium and phosphate is reported in 3 groups of paraplegic patients. Long-term therapy with G 500 increases bone loss in paralysed patients, and is contra-indicated when there is infection of the urinary tract by urea-splitting organisms.
D000293:Adolescent; D000328:Adult; D000588:Amines / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood / Q000652:urine*; D003404:Creatinine / Q000652:urine; D004359:Drug Therapy, Combination; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000097:blood / Q000652:urine*; D008715:Methionine / Q000627:therapeutic use; D008875:Middle Aged; D010018:Osteomalacia / Q000209:etiology; D010024:Osteoporosis / Q000209:etiology; D010710:Phosphates / Q000097:blood; D010758:Phosphorus / Q000652:urine*; D013119:Spinal Cord Injuries / Q000652:urine; D001750:Urinary Bladder, Neurogenic / Q000652:urine*; D014552:Urinary Tract Infections / Q000517:prevention & control; D014556:Urine; D014567:Urography
D000588:Amines; D010710:Phosphates; D010758:Phosphorus; D008715:Methionine; D003404:Creatinine; D008274:Magnesium; D002118:Calcium